We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

190 hedge funds and large institutions have $476M invested in SANGAMO THERAPEUTICS INC in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 47

18% more call options, than puts

Call options by funds: $7.91M | Put options by funds: $6.71M

3% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 31

2% less funds holding

Funds holding: 193190 (-3)

3.54% less ownership

Funds ownership: 67.7%64.16% (-3.5%)

28% less capital invested

Capital invested by funds: $657M → $476M (-$181M)

Holders
190
Holders Change
-3
Holders Change %
-1.55%
% of All Funds
4.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
64
Reduced
47
Closed
31
Calls
$7.91M
Puts
$6.71M
Net Calls
+$1.2M
Net Calls Change
+$4.04M
Name Holding Trade Value Shares
Change
Change in
Stake
Hudson Bay Capital Management
26
Hudson Bay Capital Management
Connecticut
$4.3M +$3.08M +415,000 +160%
Wells Fargo
27
Wells Fargo
California
$4.26M +$202K +27,168 +4%
CS
28
Candriam SCA
Luxembourg
$4.25M
GPP
29
Great Point Partners
Connecticut
$4.04M +$4.7M +633,505 New
JP Morgan Chase
30
JP Morgan Chase
New York
$3.97M +$2.38M +321,261 +107%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.28M +$43.5K +5,858 +1%
B
32
Bailard
California
$2.87M +$1.9M +255,900 +131%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$2.76M -$1.31M -176,294 -29%
AGA
34
Altrinsic Global Advisors
Connecticut
$2.65M
Macquarie Group
35
Macquarie Group
Australia
$2.55M
Morgan Stanley
36
Morgan Stanley
New York
$2.52M -$3.11M -419,362 -51%
PAM
37
Panagora Asset Management
Massachusetts
$2.31M +$1.45M +194,758 +116%
Nordea Investment Management
38
Nordea Investment Management
Sweden
$2.11M +$55.7K +7,504 +2%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$1.92M +$976K +131,600 +78%
MWNA
40
Marshall Wace North America
New York
$1.7M +$1.75M +235,338 +751%
Barclays
41
Barclays
United Kingdom
$1.69M +$230K +30,941 +13%
PIM
42
Platinum Investment Management
Australia
$1.57M +$368K +49,575 +25%
FCM
43
Frontier Capital Management
Massachusetts
$1.55M -$39.2K -5,287 -2%
Citigroup
44
Citigroup
New York
$1.52M +$601K +80,981 +51%
SM
45
Senvest Management
New York
$1.5M +$1.74M +235,000 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$1.49M -$35.6K -4,800 -2%
State of New Jersey Common Pension Fund D
47
State of New Jersey Common Pension Fund D
New Jersey
$1.45M
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.43M +$25.2K +3,400 +2%
DC
49
Davenport & Co
Virginia
$1.15M +$293K +39,515 +28%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$1.13M +$40.8K +5,500 +3%

SGMO Hedge Fund Activity: Q1 2020 in Review

190 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2020, worth a combined $476M — down 28% from $657M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SGMO positions and 31 closed out — a net gain of 1 holder — while 64 added to existing stakes and 47 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $17.1M. The largest seller was Wellington Management Group, exiting entirely with an estimated $64.8M sold.

  • 190 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2020, down from 193 in Q4 2019.
  • Funds reported $476M of SANGAMO THERAPEUTICS INC stock for Q1 2020, down 28% quarter-over-quarter.
  • 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2020 and 31 closed out, a net change of +1 holder.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2020 was EcoR1 Capital, an estimated $17.1M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2020 was Wellington Management Group, an estimated $64.8M sold.

Based on aggregated 13F filings for Q1 2020.